Skip to search.
 TSX Up 0.08% TSX Ventures Up 0.21%

Nektar Therapeutics (NKTR)

-NasdaqGS
12.98 Down 0.24(1.82%) Feb 26, 4:00PM EST
Add to Portfolio
Prev Close:13.22
Open:12.95
Bid:12.23 x 100
Ask:N/A
1y Target Est:18.43
Beta:1.76
Earnings Date:May 5 - May 11 (Est.)
Day's Range:12.75 - 13.28
52wk Range:10.10 - 17.53
Volume:1,096,269
Avg Vol (3m):988,238
Market Cap:1.68B
P/E (ttm):N/A
EPS (ttm):-0.43
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
NKTRDown 1.82%1.68B
BMYUp 0.39%102.15B
ENZN 0.00%48.11M
GSKUp 0.25%115.08B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):8.52
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.46
Quarterly EPS Est (Mar-15) :-0.40
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.66

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nektar Therapeutics, a clinical-stage biopharmaceutical company, develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback